Demo 3
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
- For investors
- Support
- Document Portal
Clinical Chemistry and integrated systems
to transform your laboratory.
As a team of dedicated individuals who have championed the cause of making healthcare easily accessible for all people including the remote areas, we address ourselves as the movers of the diagnostic industry.
About Us
At Anand Chemiceutics, we are a dedicated team committed to making healthcare accessible, even in the most remote areas. As trailblazers in the diagnostic industry, we strive to ensure optimal development in urban hubs by empowering laboratories with the necessary commercial and logistical support.
Our collaboration with industry leaders and our expert team enables us to deliver a robust supply chain of advanced equipment, reagents, and comprehensive technological training. With a strong presence across western and northeastern India and parts of the south, we are well-equipped to meet diverse regional demands.
Our state-of-the-art cold chain facilities and seamless logistics partnerships ensure efficient and reliable operations, helping us fulfill our mission of transforming diagnostics and healthcare across the country.
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Post-transplantation monitoring
Screening for early detection of graft rejection and minimal residual disease in bone marrow and stem cell transplant patients. Learn more
Our Product Offerings
“Early treatment made possible by more sensitive diagnostic methods is expected to improve patient survival and significantly reduce the costs for management of transplant patients.”
Dan Hauzenberger, MD., Ph.D., Karolinska University Hospital, Stockholm, Sweden